CAPPED BONUS CERTIFICATE - SARTORIUS STEDIM BIO Share Price

Certificat

N466S

FRSGE001PBB5

Real-time Euronext Paris 14:28:40 15/05/2024 BST
214 EUR +1.88% Intraday chart for CAPPED BONUS CERTIFICATE - SARTORIUS STEDIM BIO
Current month+3.57%
1 month-20.86%
Date Price Change
15/05/24 214 +1.88%
14/05/24 210 +4.08%
13/05/24 201.8 -1.63%
10/05/24 205.1 -0.40%
09/05/24 205.9 +0.71%

Real-time Euronext Paris

Last update May 15, 2024 at 02:28 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
N466S
ISINFRSGE001PBB5
Date issued 04/01/2024
Strike 286
Maturity 21/06/2024 (37 Days)
Parity 1 : 1
Emission price 247.5
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 276.5
Lowest since issue 191.9

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
209.5 EUR
Average target price
251.3 EUR
Spread / Average Target
+19.97%
Consensus
  1. Stock Market
  2. Certificates
  3. N466S Certificat